Related Experiment Video
Updated: Feb 10, 2026

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
Published on: May 23, 2025
Catch-and-Display Immunoassay as an Accessible Platform for Digital Biomarker Detection
Yuxuan Liu1, Sam Walker2, Michael Klaczko3
1Materials Science, University of Rochester, Rochester, NY 14627, United States.
We developed an accessible nanomembrane-based Catch-and-Display Immunoassay (CAD-IA) for common labs. This digital immunoassay detects biomarkers with high sensitivity using standard equipment, overcoming adoption barriers.
Area of Science:
- Biomarker detection
- Nanotechnology in diagnostics
- Immunoassay development
Background:
- Digital immunoassays offer high sensitivity for low-abundance biomarkers but face adoption barriers due to cost and complexity.
- Current commercial and lab-scale digital immunoassay platforms are often expensive or require specialized equipment and workflows.
Purpose of the Study:
- To introduce an accessible nanomembrane-based Catch-and-Display Immunoassay (CAD-IA) suitable for routine laboratory settings.
- To demonstrate CAD-IA's capability for sensitive and quantifiable biomarker detection using standard laboratory equipment.
Main Methods:
- Developed the Catch-and-Display Immunoassay (CAD-IA) using ultrathin silicon nitride membranes and fluorescent nanoparticles.
- Utilized pipette-powered filtration to capture nanoparticles within membrane pores, creating optically isolated hotspots.
- Quantified immunocomplex formation via confocal microscopy for digital signal generation on the µSiM-DX platform.
Main Results:
- CAD-IA demonstrated consistent digital outputs and linear quantification over at least two orders of magnitude for the TBI biomarker S100B.
- The assay maintained linearity in serum matrices and achieved a limit of detection (LoD) of 0.02 μg/mL with tyramide signal amplification (TSA).
- The µSiM-DX platform was manually assembled from cost-effective, mass-produced components.
Conclusions:
- CAD-IA presents a novel, accessible digital immunoassay approach for common laboratory environments.
- This method overcomes practical barriers to digital immunoassay adoption, enabling sensitive biomarker detection.
- The proof-of-concept demonstrates potential for clinically relevant diagnostics in accessible settings.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Social Foundations of Self IV: Self in Digital Communication
Detection of Gross Error: The Q Test
Detection of Black Holes
Their closest cousins are neutron stars, which are composed almost entirely of neutrons packed against each other, making them extremely dense. A neutron star has the same mass as the Sun but its diameter is only a few kilometers. Therefore, the escape velocity from their surface is close to the speed of light.
Not until the 1960s, when the first neutron...
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...

